| pubmed-article:9272389 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9272389 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9272389 | lifeskim:mentions | umls-concept:C0079488 | lld:lifeskim |
| pubmed-article:9272389 | lifeskim:mentions | umls-concept:C0080194 | lld:lifeskim |
| pubmed-article:9272389 | lifeskim:mentions | umls-concept:C0018440 | lld:lifeskim |
| pubmed-article:9272389 | lifeskim:mentions | umls-concept:C0036576 | lld:lifeskim |
| pubmed-article:9272389 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:9272389 | pubmed:dateCreated | 1997-11-5 | lld:pubmed |
| pubmed-article:9272389 | pubmed:abstractText | The influence of the proton pump inhibitor lansoprazole on strain diversity in Helicobacter pylori infected patients was investigated. Multiple isolates of Helicobacter pylori obtained pre- and post-therapy from gastric antral and body biopsies in 22 patients were compared using the random amplified polymorphic DNA-polymerase chain reaction (RAPD-PCR) for analysis. Post-therapy strains exhibiting novel RAPD-profiles were found in 5 of 22 patients (4 of 11 patients treated with lansoprazole alone and 1 of 11 patients treated with lansoprazole plus amoxicillin). Proton pump inhibition may affect the microecology of the stomach by influencing the colonisation patterns of specific strains. | lld:pubmed |
| pubmed-article:9272389 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9272389 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9272389 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9272389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9272389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9272389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9272389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9272389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9272389 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9272389 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:9272389 | pubmed:issn | 0934-9723 | lld:pubmed |
| pubmed-article:9272389 | pubmed:author | pubmed-author:Daskalopoulos... | lld:pubmed |
| pubmed-article:9272389 | pubmed:author | pubmed-author:HannaGG | lld:pubmed |
| pubmed-article:9272389 | pubmed:author | pubmed-author:HazellS LSL | lld:pubmed |
| pubmed-article:9272389 | pubmed:author | pubmed-author:MitchellH MHM | lld:pubmed |
| pubmed-article:9272389 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9272389 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:9272389 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9272389 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9272389 | pubmed:pagination | 530-2 | lld:pubmed |
| pubmed-article:9272389 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9272389 | pubmed:meshHeading | pubmed-meshheading:9272389-... | lld:pubmed |
| pubmed-article:9272389 | pubmed:meshHeading | pubmed-meshheading:9272389-... | lld:pubmed |
| pubmed-article:9272389 | pubmed:meshHeading | pubmed-meshheading:9272389-... | lld:pubmed |
| pubmed-article:9272389 | pubmed:meshHeading | pubmed-meshheading:9272389-... | lld:pubmed |
| pubmed-article:9272389 | pubmed:meshHeading | pubmed-meshheading:9272389-... | lld:pubmed |
| pubmed-article:9272389 | pubmed:meshHeading | pubmed-meshheading:9272389-... | lld:pubmed |
| pubmed-article:9272389 | pubmed:meshHeading | pubmed-meshheading:9272389-... | lld:pubmed |
| pubmed-article:9272389 | pubmed:meshHeading | pubmed-meshheading:9272389-... | lld:pubmed |
| pubmed-article:9272389 | pubmed:meshHeading | pubmed-meshheading:9272389-... | lld:pubmed |
| pubmed-article:9272389 | pubmed:meshHeading | pubmed-meshheading:9272389-... | lld:pubmed |
| pubmed-article:9272389 | pubmed:meshHeading | pubmed-meshheading:9272389-... | lld:pubmed |
| pubmed-article:9272389 | pubmed:meshHeading | pubmed-meshheading:9272389-... | lld:pubmed |
| pubmed-article:9272389 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9272389 | pubmed:articleTitle | Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection. | lld:pubmed |
| pubmed-article:9272389 | pubmed:affiliation | School of Microbiology and Immunology, University of New South Wales, Sydney, Australia. | lld:pubmed |
| pubmed-article:9272389 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9272389 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9272389 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9272389 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
